Bingo®The coronary drug delivery system is a local drug delivery device based on a balloon catheter.
The fat-soluble paclitaxel can be rapidly taken up by the vascular intimal tissue through cellular uptake and osmosis.
The paclitaxel drug carried on the surface of the balloon acts on the vascular wall of the stenosis during the expansion process.
It can effectively prevent restenosis by blocking the early proliferation initiating factors.
A new realm of coronary stenosis treatment-intervention without implantation
●A new realm of coronary stenosis treatment-intervention without implantation
●A short drug release, long-term inhibition of vascular smooth muscle cell proliferation
●No polymer/no implant, reducing the inflammatory response of the vascular intima
●Reduce the risk of stent thrombosis
●Shorten the duration of dual antiplatelet therapy
●Provide new treatment options for bifurcation lesions, in-stent restenosis, small vessel diseases, etc.
● Existing specifications
Medical device name: drug-eluting balloon catheter (trade name: Qingzhou Bingo)
Medical device manufacturer name: Liaoning Yinyi Biotechnology Co., Ltd.
Medical device registration certificate number: National Machinery Note 20173771535